 |
 |
 |
 |
 |
 |
GenSci Advantages
| Leading Manufacturing Capacity for Biogenerics | |||||
| -with quality protein therapeutics: somatropin, filgrastim, molgramostim | |||||
| Market Leader | |||||
| -Dominant 70% of domestic market share for rhGH | |||||
| Name Brands | |||||
| -Jintropin™: the leading rhGH brand in China | |||||
| -rhG-CSF is another well-received brand | |||||
| Global Player with Rapid Growth | |||||
| -Annual growth rate has been over 70% in last 5 years | |||||
| -Determined to be a global player in biogenerics | |||||
| Strong Portfolio | |||||
| -6 products on the market, 10 innovative biological products in R&D pipeline | |||||
|
